- Home
- WASH vs NMRA Comparison
WASH vs NMRA Comparison
Compare WASH & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | WASH | NMRA |
|---|---|---|
| Founded | 1800 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 554.0M |
| IPO Year | 1994 | 2023 |
Fundamental Metrics
Financial Performance| Metric | WASH | NMRA |
|---|---|---|
| Price | $33.16 | $2.50 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $30.25 | $6.57 |
| AVG Volume (30 Days) | 152.0K | ★ 715.9K |
| Earning Date | 04-20-2026 | 05-11-2026 |
| Dividend Yield | ★ 6.76% | N/A |
| EPS Growth | ★ 266.26 | 57.85 |
| EPS | ★ 2.71 | N/A |
| Revenue | ★ $229,048,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.19 | N/A |
| P/E Ratio | $12.21 | ★ N/A |
| Revenue Growth | ★ 127.57 | N/A |
| 52 Week Low | $24.97 | $0.62 |
| 52 Week High | $37.08 | $3.65 |
Technical Indicators
Market Signals| Indicator | WASH | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 38.26 |
| Support Level | $28.09 | $1.78 |
| Resistance Level | $37.08 | $2.58 |
| Average True Range (ATR) | 0.92 | 0.19 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 76.89 | 11.26 |
Price Performance
Historical ComparisonAbout WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.